A backup pathway for cysteine production could be a cancer-treatment target
A post says Montana State University researchers found that mammalian cells can make cysteine by breaking a cystine carbon–sulfur bond when disulfide reductases are deficient.
TLDR
The post cites a 2026 Nature Chemical Biology paper on a backup route for cysteine production in mammalian cells. It says scientists suspect cancer cells may use that route to withstand chemotherapy and radiation, and suggests blocking it could make existing treatments more effective.
Combined views
1.4K
1 Source, first seen 1d ago
likes
